Showing results (321-330 of 1,002) with videos related to

Sort By:
Pageof 101
Ejhaem|July 18, 2022
A meta-analysis of toxicities related to hydroxycarbamide dosing strategiesJoacy G Mathias, Vikki G Nolan, Meghan Meadows-Taylor, et al.
Ejhaem|May 21, 2026
Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in KenyaCatherine Mwalimu, Oscar Odhiambo, Elaine Mashisia, et al.
Ejhaem|June 8, 2026
Where Is the 'Oma' in Multiple Myeloma? Origins and Limitations of some Myeloma-Related TerminologyJecko Thachil, David P Steensma
Ejhaem|April 27, 2026
Steroid-Refractory Chronic Graft-Versus-Host Disease-Associated Isolated Myositis Successfully Treated With Ruxolitinib: A Case ReportTomoko Kumamoto, Kyoko Yoshihara, Ikuo Matsuda, et al.
Ejhaem|April 8, 2026
Treatment Discontinuation After Achieving MRD Negativity in Multiple Myeloma in the Pre-BCMA Era: A Prospective, Single-Centre StudyKota Sato, Kenshi Suzuki, Shotaro Sugita, et al.
Ejhaem|February 26, 2026
Comparative Efficacy of Complement Inhibitors in Complement Inhibitor-Naïve PNH: A Systematic Review With Supportive Exploratory Network Meta-Analysis of Randomized TrialsRehan Ishaque, Abdul Subhan Talpur, Hafiza Sidra, et al.
Ejhaem|February 20, 2026
Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 InhibitorsShreyans Gandhi, Markus P Radsak, Yasutaka Ueda, et al.
Ejhaem|February 19, 2026
Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell TransplantationAnna Akaogi, Junya Kanda, Fumiya Wada, et al.
Ejhaem|March 5, 2026
Real-World Analysis of Outcomes of Venetoclax+Azacitidine Versus 7+3 Induction in Acute Myeloid LeukemiaNehemias Guevara Rodriguez, Noemy Coreas Mercado, Syeda Ashna Fatima Kamal, et al.
Ejhaem|August 27, 2025
An Unusual Cause of Hexokinase 1 Deficiency-Case ReportGonench Kilich, Kelly Maurer, Tanaya Jadhav, et al.
Pageof 101